Navigation Links
Wintherix Announces Potent Small Molecule Wnt Activators for Bone Healing.
Date:9/14/2010

SAN DIEGO, Sept. 14 /PRNewswire/ -- Wintherix, LLC, a privately held biotechnology company focusing on bone healing and regenerative medicine, today announced that WX04554, a potent small molecule activator of the Wnt pathway, has been designated as a lead drug for clinical development in bone healing and repair indications.

Pre-clinical studies indicate that this class of small molecules potently activates the Wnt pathway and causes bones to heal and become stronger by forcing stem cells to become bone forming cells called osteoblasts.  "The proof-of-concept animal studies showing faster and stronger bone formation lead us to be very excited. We believe it has potential for human therapeutic application in a number of diseases including bone fracture repair, spinal fusions, and possibly as a preventative for osteoporosis patients," stated John Hood, CSO of Wintherix. "Having reached this milestone, we expect WX04554 will be in the clinic by late 2011, and we're now currently exploring strategic partnerships," added Dr. Hood.

Trauma is the second biggest cost item to the US healthcare system at over $55B/yr, of which almost half is used to treat broken bones. And with 20% of osteoporotic hip fracture patients dying within a year, the ability to reverse bone thinning and heal at-risk patients would be a significant advance to health care.

Wintherix is located in Sorrento Valley in San Diego, CA. For more information, please visit us at www.wintherix.com.


'/>"/>
SOURCE Wintherix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
(Date:5/10/2017)... , May 10, 2017 Global Health ... Latin America , published its 2017 ranking ... ranking is based on extensive data analysis from GHI,s ... largest hospitals database for the region. The GHI database covers ... , offering more than 130 data points for each institution ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/23/2017)... NV (PRWEB) , ... May 23, 2017 , ... ... Dental Specialists, are educating patients on peri-implantitis in Las Vegas, NV, ... to receive a custom gum disease consultation and leading care for peri-implantitis, with ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... Horeb, WI (PRWEB) , ... May 23, 2017 , ... ... invited to call Dr. Angela Cotey’s practice to schedule an appointment, with or without ... services, and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative to ...
(Date:5/22/2017)... ... ... Today, Our Urgent Care celebrates the grand opening of its newest urgent ... opening over a month ago, Our Urgent Care Washington has enjoyed serving Franklin County ... Care walk-in clinic is located at 3195 Phoenix Center Dr., Washington, MO 63090 in ...
(Date:5/22/2017)... San Antonio, TX (PRWEB) , ... May 22, 2017 , ... ... It starts with a body squatted, stretched, jumped, toned and shaped through fitness programs. ... And it is, of course, finished off with an irresistible, radiant smile. CDA ...
Breaking Medicine News(10 mins):